1. Home
  2. BW vs VOR Comparison

BW vs VOR Comparison

Compare BW & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

BUY

Current Price

$4.18

Market Cap

1.2B

Sector

Industrials

ML Signal

BUY

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$18.31

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BW
VOR
Founded
1867
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
BW
VOR
Price
$4.18
$18.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$22.00
★ $39.00
AVG Volume (30 Days)
★ 4.8M
835.7K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.46
N/A
EPS
★ N/A
N/A
Revenue
★ $1,062,388,000.00
N/A
Revenue This Year
$78.48
N/A
Revenue Next Year
$22.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.12
$6.50
52 Week High
$22.03
$28.66

Technical Indicators

Market Signals
Indicator
BW
VOR
Relative Strength Index (RSI) 23.49 41.82
Support Level N/A $17.35
Resistance Level $6.14 $18.44
Average True Range (ATR) 0.31 1.17
MACD -0.02 0.10
Stochastic Oscillator 6.65 22.94

Price Performance

Historical Comparison
BW
VOR

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is an energy technologies provider offering energy and emissions control solutions to a broad range of industrial, electrical utility, municipal, and other customers. It offers technologies that utilize coal, natural gas, hydrogen, waste, and biomass to produce energy, environmental solutions, and carbon capture systems. The company's product portfolio comprises steam generation systems, environmental solutions, combustion and fuel systems, and related equipment and services. Additionally, it offers specialized technologies (BrightLoop) in industrial energy production, including hydrogen and syngas. Geographically, the company generates maximum revenue from the United States, and the rest from Canada, the UK, Indonesia, the Philippines, and other markets.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: